Inflamax   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mississauga Canada (2012)
Status: Acquired by Cliantha Research Limited (2017)

Organization Overview

First Clinical Trial
2013
NCT01919554
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Inflamax Research | Inflamax Research Ltd. | Inflamax Researc Incorporated